Testosterone undecanoate - Zhejiang Xianju Pharmaceutical
Alternative Names: SitelongLatest Information Update: 17 Sep 2021
At a glance
- Originator Zhejiang Xianju Pharmaceutical
- Developer National Research Institute for Family Planning; University of Washington; Zhejiang Xianju Pharmaceutical
- Class Anabolic steroids; Androstenols; Hormonal replacements; Small molecules; Testosterone congeners
- Mechanism of Action Testosterone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Pregnancy